NEW YORK (GenomeWeb) – NanoString Technologies said after the close of the market Tuesday that it will develop a companion diagnostic test for Celgene's Revlimid (lenalidomide), which the firm is developing for diffuse large B-cell lymphoma.
NEW YORK (GenomeWeb) — Idera Pharmaceuticals said today that it has entered into an agreement with Abbott to develop an in vitro companion diagnostic test for use in Idera's clinical development programs to treat certain genetically defined forms of B-cell lymphoma with its lead drug can
NEW YORK (GenomeWeb) – Cancer Genetics today said that it has received CLIA and New York State approvals to offer its mature B-cell neoplasm array for follicular lymphoma (MatBA-FL) and mantle-cell lymphoma (MatBA-MCL) as laboratory-developed tests.
NEW YORK (GenomeWeb News) – Cancer Genetics and Roche Servicios today announced the expansion of an agreement covering molecular diagnostic testing in Central America and the Caribbean.
Roche Servicios is an affiliate of Roche.
Scientists from the Fred Hutchinson Cancer Research Center and recent spinout company Adaptive Biotechnologies have published research demonstrating that the use of a synthetic analogue of a somatically rearranged immune cell receptor locus can be used to quantify and correct mul